Ignite Creation Date:
2025-12-24 @ 1:59 PM
Ignite Modification Date:
2026-01-02 @ 10:33 AM
Study NCT ID:
NCT02420795
Status:
TERMINATED
Last Update Posted:
2022-04-04
First Post:
2015-04-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-03
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-16
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-15
First Submit QC Date:
None
Study First Post Date:
2015-04-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-11-10
Results First Submit QC Date:
None
Results First Post Date:
2022-04-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-30
Last Update Post Date:
2022-04-04
Last Update Post Date Type:
ACTUAL